Home NDC 63304-538 Lisinopril and Hydrochlorothiazide
Product NDC 63304-538
11-digit product format 633040538
Labeler code 63304
Product ID 63304-538_b119c7cd-d261-41ca-94a4-d01ace9e4929
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Lisinopril and hydrochlorothiazide
Dosage form TABLET
Route ORAL
Labeler Ranbaxy Pharmaceuticals Inc.
Application ANDA076007
Marketing category ANDA
Marketing start 2002-07-02
Marketing end 0000-00-00
Substance LISINOPRIL; HYDROCHLOROTHIAZIDE
Active strength 20 mg/1; mg/1
Pharmacologic classes Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
NDC exclude flag E
Listing certified through 2018-12-31
Current FDA listing Historical FDA.report record
Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 2 · 66 matching rows.
View current auxiliary records. · View the auxiliary file history.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A076007-001 LISINOPRIL AND HYDROCHLOROTHIAZIDE HYDROCHLOROTHIAZIDE; LISINOPRIL 12.5MG;10MG TABLET / ORAL AB 2002-07-01 A076007-002 LISINOPRIL AND HYDROCHLOROTHIAZIDE HYDROCHLOROTHIAZIDE; LISINOPRIL 12.5MG;20MG TABLET / ORAL AB 2002-07-01 A076007-003 LISINOPRIL AND HYDROCHLOROTHIAZIDE HYDROCHLOROTHIAZIDE; LISINOPRIL 25MG;20MG TABLET / ORAL AB 2002-07-01
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 3 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 135 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 A076007-001 LISINOPRIL AND HYDROCHLOROTHIAZIDE 12.5MG;10MG TABLET / ORAL AB 2002-07-01 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A076007-002 LISINOPRIL AND HYDROCHLOROTHIAZIDE 12.5MG;20MG TABLET / ORAL AB 2002-07-01 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A076007-003 LISINOPRIL AND HYDROCHLOROTHIAZIDE 25MG;20MG TABLET / ORAL AB 2002-07-01 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 A076007-001 LISINOPRIL AND HYDROCHLOROTHIAZIDE 12.5MG;10MG TABLET / ORAL AB 2002-07-01 c2088c7a36db…2026-10-15 13:18:30 2026-09 A076007-002 LISINOPRIL AND HYDROCHLOROTHIAZIDE 12.5MG;20MG TABLET / ORAL AB 2002-07-01 c2088c7a36db…2026-10-15 13:18:30 2026-09 A076007-003 LISINOPRIL AND HYDROCHLOROTHIAZIDE 25MG;20MG TABLET / ORAL AB 2002-07-01 c2088c7a36db…2026-09-14 22:38:34 2026-08 A076007-001 LISINOPRIL AND HYDROCHLOROTHIAZIDE 12.5MG;10MG TABLET / ORAL AB 2002-07-01 84e616aacf4f…2026-09-14 22:38:34 2026-08 A076007-002 LISINOPRIL AND HYDROCHLOROTHIAZIDE 12.5MG;20MG TABLET / ORAL AB 2002-07-01 84e616aacf4f…2026-09-14 22:38:34 2026-08 A076007-003 LISINOPRIL AND HYDROCHLOROTHIAZIDE 25MG;20MG TABLET / ORAL AB 2002-07-01 84e616aacf4f…2026-08-18 06:07:40 2026-07 A076007-001 LISINOPRIL AND HYDROCHLOROTHIAZIDE 12.5MG;10MG TABLET / ORAL AB 2002-07-01 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A076007-002 LISINOPRIL AND HYDROCHLOROTHIAZIDE 12.5MG;20MG TABLET / ORAL AB 2002-07-01 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A076007-003 LISINOPRIL AND HYDROCHLOROTHIAZIDE 25MG;20MG TABLET / ORAL AB 2002-07-01 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A076007-001 LISINOPRIL AND HYDROCHLOROTHIAZIDE 12.5MG;10MG TABLET / ORAL AB 2002-07-01 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A076007-002 LISINOPRIL AND HYDROCHLOROTHIAZIDE 12.5MG;20MG TABLET / ORAL AB 2002-07-01 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A076007-003 LISINOPRIL AND HYDROCHLOROTHIAZIDE 25MG;20MG TABLET / ORAL AB 2002-07-01 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A076007-001 LISINOPRIL AND HYDROCHLOROTHIAZIDE 12.5MG;10MG TABLET / ORAL AB 2002-07-01 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A076007-002 LISINOPRIL AND HYDROCHLOROTHIAZIDE 12.5MG;20MG TABLET / ORAL AB 2002-07-01 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A076007-003 LISINOPRIL AND HYDROCHLOROTHIAZIDE 25MG;20MG TABLET / ORAL AB 2002-07-01 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A076007-001 LISINOPRIL AND HYDROCHLOROTHIAZIDE 12.5MG;10MG TABLET / ORAL AB 2002-07-01 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A076007-002 LISINOPRIL AND HYDROCHLOROTHIAZIDE 12.5MG;20MG TABLET / ORAL AB 2002-07-01 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A076007-003 LISINOPRIL AND HYDROCHLOROTHIAZIDE 25MG;20MG TABLET / ORAL AB 2002-07-01 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A076007-001 LISINOPRIL AND HYDROCHLOROTHIAZIDE 12.5MG;10MG TABLET / ORAL AB 2002-07-01 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A076007-002 LISINOPRIL AND HYDROCHLOROTHIAZIDE 12.5MG;20MG TABLET / ORAL AB 2002-07-01 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A076007-003 LISINOPRIL AND HYDROCHLOROTHIAZIDE 25MG;20MG TABLET / ORAL AB 2002-07-01 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A076007-001 LISINOPRIL AND HYDROCHLOROTHIAZIDE 12.5MG;10MG TABLET / ORAL AB 2002-07-01 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A076007-002 LISINOPRIL AND HYDROCHLOROTHIAZIDE 12.5MG;20MG TABLET / ORAL AB 2002-07-01 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A076007-003 LISINOPRIL AND HYDROCHLOROTHIAZIDE 25MG;20MG TABLET / ORAL AB 2002-07-01 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A076007-001 LISINOPRIL AND HYDROCHLOROTHIAZIDE 12.5MG;10MG TABLET / ORAL AB 2002-07-01 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A076007-002 LISINOPRIL AND HYDROCHLOROTHIAZIDE 12.5MG;20MG TABLET / ORAL AB 2002-07-01 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A076007-003 LISINOPRIL AND HYDROCHLOROTHIAZIDE 25MG;20MG TABLET / ORAL AB 2002-07-01 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A076007-001 LISINOPRIL AND HYDROCHLOROTHIAZIDE 12.5MG;10MG TABLET / ORAL AB 2002-07-01 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A076007-002 LISINOPRIL AND HYDROCHLOROTHIAZIDE 12.5MG;20MG TABLET / ORAL AB 2002-07-01 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A076007-003 LISINOPRIL AND HYDROCHLOROTHIAZIDE 25MG;20MG TABLET / ORAL AB 2002-07-01 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A076007-001 LISINOPRIL AND HYDROCHLOROTHIAZIDE 12.5MG;10MG TABLET / ORAL AB 2002-07-01 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A076007-002 LISINOPRIL AND HYDROCHLOROTHIAZIDE 12.5MG;20MG TABLET / ORAL AB 2002-07-01 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A076007-003 LISINOPRIL AND HYDROCHLOROTHIAZIDE 25MG;20MG TABLET / ORAL AB 2002-07-01 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A076007-001 LISINOPRIL AND HYDROCHLOROTHIAZIDE 12.5MG;10MG TABLET / ORAL AB 2002-07-01 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A076007-002 LISINOPRIL AND HYDROCHLOROTHIAZIDE 12.5MG;20MG TABLET / ORAL AB 2002-07-01 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A076007-003 LISINOPRIL AND HYDROCHLOROTHIAZIDE 25MG;20MG TABLET / ORAL AB 2002-07-01 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A076007-001 LISINOPRIL AND HYDROCHLOROTHIAZIDE 12.5MG;10MG TABLET / ORAL AB 2002-07-01 d06236e962d9…
Observed Orange Book normalized TE history# Normalized TE history page 3 of 4 · 135 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 63304-538-01 Lisinopril and Hydrochlorothiazide 100 in 1 BOTTLE TABLET 100 6 63304-538-05 Lisinopril and Hydrochlorothiazide 500 in 1 BOTTLE TABLET 500 6
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded HYDROCHLOROTHIAZIDE ACTIVE INGREDIENT 0J48LPH2TH LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLET [RANBAXY PHARMACEUTICALS INC.] 6 LISINOPRIL ACTIVE INGREDIENT E7199S1YWR LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLET [RANBAXY PHARMACEUTICALS INC.] 6 HYDROCHLOROTHIAZIDE ACTIVE MOIETY 0J48LPH2TH LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLET [RANBAXY PHARMACEUTICALS INC.] 6 LISINOPRIL ANHYDROUS ACTIVE MOIETY 7Q3P4BS2FD LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLET [RANBAXY PHARMACEUTICALS INC.] 6 ANHYDROUS DIBASIC CALCIUM PHOSPHATE INACTIVE INGREDIENT L11K75P92J LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLET [RANBAXY PHARMACEUTICALS INC.] 6 FD&C BLUE NO. 2 INACTIVE INGREDIENT L06K8R7DQK LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLET [RANBAXY PHARMACEUTICALS INC.] 6 FERRIC OXIDE RED INACTIVE INGREDIENT 1K09F3G675 LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLET [RANBAXY PHARMACEUTICALS INC.] 6 FERRIC OXIDE YELLOW INACTIVE INGREDIENT EX438O2MRT LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLET [RANBAXY PHARMACEUTICALS INC.] 6 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLET [RANBAXY PHARMACEUTICALS INC.] 6 MANNITOL INACTIVE INGREDIENT 3OWL53L36A LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLET [RANBAXY PHARMACEUTICALS INC.] 6 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLET [RANBAXY PHARMACEUTICALS INC.] 6 HYDROCHLOROTHIAZIDE ACTIVE INGREDIENT 0J48LPH2TH LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLET [PHYSICIANS TOTAL CARE, INC.] 5 LISINOPRIL ACTIVE INGREDIENT E7199S1YWR LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLET [PHYSICIANS TOTAL CARE, INC.] 5 HYDROCHLOROTHIAZIDE ACTIVE MOIETY 0J48LPH2TH LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLET [PHYSICIANS TOTAL CARE, INC.] 5 LISINOPRIL ACTIVE MOIETY E7199S1YWR LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLET [PHYSICIANS TOTAL CARE, INC.] 5 DIBASIC CALCIUM PHOSPHATE DIHYDRATE INACTIVE INGREDIENT O7TSZ97GEP LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLET [PHYSICIANS TOTAL CARE, INC.] 5 FD&C BLUE NO. 2 INACTIVE INGREDIENT L06K8R7DQK LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLET [PHYSICIANS TOTAL CARE, INC.] 5 FERRIC OXIDE RED INACTIVE INGREDIENT 1K09F3G675 LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLET [PHYSICIANS TOTAL CARE, INC.] 5 FERRIC OXIDE YELLOW INACTIVE INGREDIENT EX438O2MRT LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLET [PHYSICIANS TOTAL CARE, INC.] 5 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLET [PHYSICIANS TOTAL CARE, INC.] 5 MANNITOL INACTIVE INGREDIENT 3OWL53L36A LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLET [PHYSICIANS TOTAL CARE, INC.] 5 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLET [PHYSICIANS TOTAL CARE, INC.] 5
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 63304-538 LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLET [RANBAXY PHARMACEUTICALS INC.] 6 Legacy NDC, 2 package rows 20131226_b8f4d730-fd8e-4692-aabd-e2b7e63fabe1.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Status 63304-538-01 63304053801 100 in 1 BOTTLE Historical 63304-538-05 63304053805 500 in 1 BOTTLE Historical